Effects of plant extract neferine on cyclic adenosine monophosphate and cyclic guanosine monophosphate levels in rabbit corpus cavernosum in vitro

Asian Journal of Andrology

Volumn 10, Issue 2, 2008, Pages 307-312

  Chen, Jun ^a   Liu, Ji Hong ^a   Wang, Tao ^a   Xiao, Heng Jun ^b   Yin, Chun Ping ^c   Yang, Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Neferine; Rabbit corpus cavernosum

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENYLATE CYCLASE INHIBITOR; ALKALOID; CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; IODINE 125; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; NEFERINE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; PROSTAGLANDIN E1;

ANIMAL TISSUE; ARTICLE; CHINA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ERECTILE DYSFUNCTION; IN VITRO STUDY; MALE; MUSCLE RELAXATION; NELUMBO; NONHUMAN; PLANT SEED; RABBIT; RADIOIMMUNOASSAY;

ANIMALS; BENZYLISOQUINOLINES; CYCLIC AMP; CYCLIC GMP; DRUGS, CHINESE HERBAL; ERECTILE DYSFUNCTION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NELUMBO; PENILE ERECTION; PENIS; PHYTOTHERAPY; PLANT EXTRACTS; RABBITS; RADIOIMMUNOASSAY; SEEDS; VASODILATOR AGENTS;

EID: 40349113012     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2008.00342.x     Document Type: Article

References (34)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
2. Montorsi F, Salonia A, Deho' F, Cestari A, Guazzoni G, Rigatti P, et al. Pharmacological management of erectile dysfunction. BJU Int 2003; 91: 446-54.
3. Chen J, Liu JH. Advance of Chinese herbs in improving the relaxation effect of corporal smooth muscle. Zhonghua Nan Ke Xue 2003; 9: 615-8.
4. Chen X, Lee TJ. Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br J Pharmacol 1995; 115: 15-8.
5. Paick JS, Lee JH. An experimental study of the effect of ginkgo biloba extract on the human rabbit corpus cavernosum tissue. J Urol 1996; 156: 1876-80.
6. Chen J, Chiou WF, Chen CC, Chen CF. Effect of the plant-extract osthole on the relaxation of rabbit corpus cavernosum tissue in vitro. J Urol 2000; 163: 1975-80.
7. Chiou WF, Huang YL, Chen CF, Chen CC. Vasorelaxing effect of coumarins from Cnidium monnieri on rabbit corpus cavernosum. Planta Med 2001; 67: 282-4.
8. Chiou WF, Chen CF. Pharmacological profile of evodiamine in isolated rabbit corpus cavernosum. Eur J Pharmacol 2002; 446: 151-9.
9. Chiou WF, Chen J, Chen CF. Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit. Br J Pharmacol 1998; 125: 1677-84.
10. Xiao HJ, Liu JH, Wang SG, Chen Z, Li Y, Cao ZG. Effect of ligustrazine on the contraction of isolated rabbit corporal cavernosum tissues. Asian J Androl 2002; 4 (Suppl 3): 107.
11. Chen J, Qi J, Chen F, Liu JH, Wang T, Yang J, et al. Relaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro. Asian J Androl 2007,9: 795-800.
12. Chen J, Liu JH, Jiang ZJ, Wang T, Liu B, Yang J, et al. Effects of neferine on cytosolic free calcium concentration in corpus cavernosum smooth muscle cells of rabbits. Andrologia 2007; 39: 141-5.
13. Chen J, Liu JH, Xiao HJ, Wang T, Chen Z, Sun CL. The relaxation effects of Tetrandrine on the corpus cavernosum tissue of rabbit in vitro. Zhonghua Nan Ke Xue 2003; 9: 234-6.
14. Chen J, Liu JH, Wang T, Wang SG, Yin CP, Xiao HJ, et al. The relaxation effects of six extracts from Chinese herbs on the corpus cavernosum tissue of rabbit in vitro. Zhonghua Nan Ke Xue 2005; 11: 793-5, 799.
15. Liu JH, Chen J, Wang T, Liu B, Yang J, Chen XW, et al. Effects of tetrandrine on cytosolic free calcium concentration in corpus cavernosum smooth muscle cells of rabbits. Asian J Androl 2006, 8: 405-9.
16. Liu JH, Chen J. Ion channels and penile erection. Zhonghua Nan Ke Xue 2004; 10: 403-6.
17. Sáenz de Tejada I, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R, et al. Pathophysiology of erectile dysfunction. J Sex Med 2005; 2: 26-39.
18. Dean RC, Lue TF. Physiology of penile erection and patho-physiology of erectile dysfunction. Urol Clin North Am 2005; 32: 379-95.
19. Guo Z. Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias. Zhonghua Xin Xue Guan Bing Za Zhi 1992; 20: 119-22, 134.
20. Qian JQ. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacol Sin 2002; 23: 1086-92.
21. Feng Y, Wu J, Cong R, Wang C, Zong Y, Feng Z. The effect of neferine on foam cell formation by anti-low density lipoprotein oxidation. J Tongji Med Univ 1998; 18: 134-6.
22. Yu J, Hu WS. Effects of neferine on platelet aggregation in rabbits. Yao Xue Xue Bao 1997; 32: 1-4.
23. Wu YM, Jia JF, Li YJ. Protective effcet of neferine on oxygen free radical-induced damage of vascular endothelial cell. Chin J Pharmacol and Toxicol 1997; 11: 27.
24. Cao JG, Tang XQ, Shi SH. Multidrug resistance reversal in human gastric carcinoma cells by neferine. World J Gastroenterol 2004; 10: 3062-4.
25. Kotera J, Sasaki T, Omori K. Recent progress in cyclic nucleotide phosphodiesterase research: Isozymes, functions, and inhibitors. Nippon Yakurigaku Zasshi 2005; 126: 121-7.
26. Uckert S, Küthe A, Stief CG, Jonas U. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. World J Urol 2001; 19: 14-22.
27. Küthe A, Montorsi F, Andersson KE, Stief CG. Phosphodiesterase inhibitors for the treatment of erectile dysfunction. Curr Opin Investig Drugs 2002; 3: 1489-95.
28. Taher A, Meyer M, Stief CG, Jonas U, Forssmann WG. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World J Urol 1997; 15: 32-5.
29. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, et al. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
30. Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 1998; 159: 1390-3.
31. Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, et al. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 2001; 13: 282-90.
32. Padma-Nathan H, Montorsi F, Giuliano F, Meuleman E, Auerbach S, Eardley I, et al. Vardenafil restores erectile function to normal range in men with erectile dysfunction. J Sex Med 2007; 4: 152-61.
33. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-404.
34. Qiu Y, Kraft P, Lombardi E, Clancy J. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum. J Urol 2000; 164: 882-6.